CIBCX
Price
$81.05
Change
-$0.64 (-0.78%)
Updated
Jun 10 closing price
Net Assets
127.98B
CVLCX
Price
$11.58
Change
-$0.18 (-1.53%)
Updated
Jun 10 closing price
Net Assets
363.24M
Interact to see
Advertisement

CIBCX vs CVLCX

Header iconCIBCX vs CVLCX Comparison
Open Charts CIBCX vs CVLCXBanner chart's image
CIBCX vs CVLCX Comparison Chart in %
View a ticker or compare two or three
VS
CIBCX vs. CVLCX commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIBCX is a Buy and CVLCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIBCX has more cash in the bank: 128B vs. CVLCX (363M). CIBCX pays higher dividends than CVLCX: CIBCX (2.02) vs CVLCX (0.00). CIBCX was incepted earlier than CVLCX: CIBCX (25 years) vs CVLCX (30 years). CVLCX (2.21) is less costly to investors than CIBCX (1.33). CVLCX is a more actively managed with annual turnover of: 123.00 vs. CIBCX (50.00). CIBCX has a lower initial minimum investment than CVLCX: CIBCX (250) vs CVLCX (2500). CVLCX annual gain was more profitable for investors over the last year : 11.15 vs. CIBCX (9.47). CIBCX return over 5 years is better than : 29.10 vs. CVLCX (14.87).
CIBCXCVLCXCIBCX / CVLCX
Total Expense Ratio1.331.9768%
Annual Report Gross Expense Ratio1.332.2160%
Fund Existence25 years30 years-
Gain YTD5.37213.73339%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets128B363M35,262%
Annual Yield % from dividends2.020.00-
Returns for 1 year9.4711.1585%
Returns for 3 years36.1539.5691%
Returns for 5 years29.1014.87196%
Returns for 10 years58.7957.19103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATLCP23.94-0.13
-0.54%
Atlanticus Holdings Corp
GRC79.45-1.66
-2.05%
Gorman-Rupp Company (The)
CTOR0.70-0.02
-2.76%
Citius Oncology Inc
ICLR144.50-7.32
-4.82%
ICON plc
OVID2.28-0.15
-5.99%
Ovid Therapeutics